Who Owns Aura Biosciences Stock?
NASDAQ: AURAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.45%
- Institutions (% of float)
- 100.99%
- Held by insiders
- 2.52%
- Institutional holders
- 203
- Institutions 97.5%
- Insiders 2.5%
- Public and other 0.0%
Who owns Aura Biosciences stock?
Institutional investors own about 98.4% of Aura Biosciences's shares, spread across 203 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.52% of AURA.
The largest institutional holders are TCG Crossover Management, LLC (9.16%), Montanova Capital LLC (6.92%) and Frazier Life Sciences Management, L.P. (6.82%). Together, the top 10 institutions control 52.0% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their AURA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AURA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| TCG Crossover Management, LLC | 9.53M | 9.16% | +100.0% |
| Montanova Capital LLC | 7.21M | 6.92% | +64.8% |
| Frazier Life Sciences Management, L.P. | 7.10M | 6.82% | +39.2% |
| Long Focus Capital Management, LLC | 5.12M | 4.92% | +10.8% |
| Blackrock Inc. | 4.71M | 4.52% | +31.3% |
| Adage Capital Partners GP L.L.C. | 4.64M | 4.46% | -4.9% |
| Caligan Partners, LP | 4.30M | 4.13% | +1769.9% |
| Vanguard Capital Management LLC | 4.10M | 3.94% | +82.7% |
| FCPM III Services B.V. | 4.05M | 3.90% | +100.0% |
| Orbimed Advisors LLC. | 3.33M | 3.20% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AURA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.90M | 2.79% |
| iShares Trust-iShares Russell 2000 ETF | 1.43M | 1.37% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.11M | 1.06% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 938.13K | 0.90% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 765.62K | 0.74% |
| iShares Trust-iShares Biotechnology ETF | 518.95K | 0.50% |
| iShares Trust-iShares Russell 2000 Growth ETF | 504.94K | 0.49% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 492.90K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 445.17K | 0.43% |
| Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF | 327.11K | 0.31% |
Frequently asked questions
Who is the largest shareholder of Aura Biosciences?
TCG Crossover Management, LLC is the largest institutional shareholder of AURA, owning 9.16% of shares outstanding (9.53M shares) as of its latest 13F filing.
What percentage of Aura Biosciences is owned by institutions?
Institutions own about 98.4% of AURA shares and 101.0% of the public float.
How much of Aura Biosciences do insiders own?
Insiders, such as officers and directors, own about 2.52% of AURA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.